Click here for additional news beyond press releases.


Current | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000


December 6, 2005
Celera Diagnostics Discovers Group of Genes Strongly Associated with Late-Onset Alzheimer’s Disease
November 16, 2005
Celera Genomics Presents Further Data From Its Histone Deacetylase Inhibitor Program As Cancer Therapeutics
October 27, 2005
Celera Genomics Reports First Quarter Fiscal 2006 Results
additional: Applera Corporation Teleconference - October 27, 2005
October 12, 2005
Applied Biosystems Group And Celera Genomics Group First Quarter Fiscal 2006 Financial Results And Conference Call Schedules for October 27, 2005
September 21, 2005
Celera Genomics and Celera Diagnostics to Webcast Presentation at UBS Global Life Sciences Conference
September 20, 2005
Celera Genomics Initiates Phase I Clinical Trial for Cathepsin S Inhibitor for the Treatment of Psoriasis
August 29, 2005
Celera Diagnostics Identifies Novel Genetic Markers Linked to Increased Risk of Heart Attack
August 18, 2005
Celera Genomics and Seattle Genetics Announce Target Selection from Research Collaboration in Cancer
July 27, 2005
Celera Genomics Reports Fourth Quarter and Fiscal 2005 Results
additional: Applera Corporation Teleconference - July 27, 2005
July 13, 2005
Celera Genomics Initiates Phase I Clinical Trial for its Novel HDAC Inhibitor, CRA-024781, in Patients with Cancer
May 24, 2005
Celera Genomics Presents Data Describing the Efficacy of its Tryptase Inhibitor for the Treatment of Allergic Asthma
May 2, 2005
Celera Genomics Files Investigational New Drug Application for Novel HDAC Inhibitor, CRA-024781
April 29, 2005
Celera Genomics and Celera Diagnostics to Webcast Presentation at Morgan Stanley Healthcare Conference
April 26, 2005
Celera Genomics Reports Third Quarter Fiscal 2005 Results
additional: Management Remarks for Third Quarter Fiscal 2005 Earnings Call
April 18, 2005
Celera Genomics Presents Preclinical Data Characterizing its Novel Human Histone Deacetylase (HDAC) Inhibitor as a Cancer Therapeutic
April 14, 2005
Applied Biosystems Group and Celera Genomics Group Third Quarter Fiscal 2005 Financial Results and Conference Call Scheduled for April 26, 2005
April 14, 2005
Celera Genomics and Abbott Announce Target Selection from Research Collaboration
April 1, 2005
Celera Genomics and Celera Diagnostics to Webcast Investor Presentation
March 8, 2005
Celera Genomics and Celera Diagnostics to Webcast Presentation at SG Cowen Healthcare Conference
February 16, 2005
Celera Genomics and Celera Diagnostics to Webcast Presentation at Bio Ceo & Investor Conference
January 27, 2005
Celera Genomics Reports Second Quarter Fiscal 2005 Results
additional: Applera Corporation Teleconference - January 27, 2005
January 21, 2005
Celera Genomics and Celera Diagnostics to Webcast Presentation at Piper Jaffray Health Care Conference
January 20, 2005
Applera Corporation Announces Acceleration of Stock Option Vesting
January 14, 2005
Applied Biosystems Group and Celera Genomics Group Second Quarter Fiscal 2005 Financial Results and Conference Call Scheduled for January 27, 2005
January 5, 2005
Celera Genomics And Celera Diagnostics To Webcast Presentation At JPMorgan Healthcare Conference